A signature of the integrin CD103+ and the ectonucleotidase CD39+ in CD8+ TILs has been shown to be associated with clones most expanded in the tumour relative to the periphery, expressing high levels of exhaustion markers and a TRM phenotype, and enriched in cells able to kill autologous melanoma tumours [79]. This evidence concerns the gene CD8A and melanoma.